MedTrace Logo

Health in Work - a Measure for Increased Coping and Work Inclusion

NCT04000035 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1383

Last updated 2024-12-16

No results posted yet for this study

Summary

Health in work - a measure for increased coping and work participation

-An effect analysis of a health- and work environment intervention at the workplace. Part 1:quantitative data collection

The main objective of this study is to investigate the effect of the workplace intervention in the new Norwegian national programme Health in work (HelseIArbeid) through a pragmatic cluster-randomized study.

The main hypothesis is that this interdisciplinary health and welfare intervention at the workplace reduces sick leave and improves mastering of common health problems more efficiently than a conventional welfare intervention. More specifically, it is hypothesized that the Health in work intervention has a better cost-effectiveness in terms of sick leave, use of health services and coping with common health problems indicated by an increased health-related quality of life.

Conditions

Interventions

OTHER

Health and work environment information and processes

see arm/group description

Sponsors & Collaborators

  • University of Tromso

    collaborator OTHER

  • Norwegian Labour and Welfare Administration

    collaborator OTHER

  • Helse Nord

    collaborator INDUSTRY

  • University Hospital of North Norway

    lead OTHER

Principal Investigators

  • Nils Fleten, Phd · UiT The artic University of Norway / Norwegian Welfare Service Troms

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-14
Primary Completion
2023-07-01
Completion
2035-07-01

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04000035 on ClinicalTrials.gov